Infectious Diseases (all articles)
Choosing Wisely in the COVID-19 Era: Preventing Harm to Healthcare Workers
22 May, 2020 | 04:58h | UTC
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
22 May, 2020 | 04:59h | UTCCommentary: Lungs of deceased COVID-19 patients show distinctive features – Brigham and Women’s Hospital
Related: Postmortem Examination of Patients With COVID-19 – JAMA AND Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine AND Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
Opinion: Ten Reasons why Immunity Passports are a Bad Idea
22 May, 2020 | 04:54h | UTCTen reasons why immunity passports are a bad idea – Nature
Related: Ethical and Legal Challenges of COVID-19 Immunity Certificates (articles and commentaries on the subject) AND Privileges and Immunity Certification During the COVID-19 Pandemic – JAMA AND The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”) – JAMA
Which Interventions Work Best in a Pandemic?
22 May, 2020 | 04:50h | UTCWhich interventions work best in a pandemic? – Science
How Coronavirus Lockdowns Stopped Flu in its Tracks
22 May, 2020 | 04:53h | UTCHow coronavirus lockdowns stopped flu in its tracks – Nature
“Reported rates of influenza and other infections have fallen sharply, but some communicable diseases may see a rise.”
15 Drugs Being Tested to Treat COVID-19 and How They Would Work
22 May, 2020 | 04:52h | UTC15 drugs being tested to treat COVID-19 and how they would work – Nature
[Preprint] IL6 Inhibition in Critically Ill COVID-19 Patients is Associated with Increased Secondary Infections
22 May, 2020 | 04:44h | UTC
Opinion: Revisiting the No Visitors Policy
22 May, 2020 | 04:43h | UTCRevisiting the No Visitors Policy – CMAJ Blogs
“I follow the policy, as I must, but neither my heart nor my mind believe that the harm we aim to prevent with current no visitors edicts outweighs the harm we are causing.”
[Preprint] Estimating the Number of Deaths that Could Have Been Prevented with Earlier Lockdown Measures
22 May, 2020 | 04:45h | UTCDifferential Effects of Intervention Timing on COVID-19 Spread in the United States – medRxiv
Commentaries: At Least 54,000 U.S. Deaths Could Have Been Avoided If Lockdown Had Come Two Weeks Earlier – Forbes AND Lockdown Delays Cost at Least 36,000 Lives, Data Show – The New York Times AND Latest Columbia COVID-19 Projections: Delayed Response to Rebound Would Cost Lives – Columbia University, Mailman School of Public Health AND Delayed Social Restrictions Led to 36,000 Deaths – U.S. News AND About 83% of US coronavirus deaths could have been avoided if lockdowns were imposed March 1, researchers estimate – Business Insider
SARS-CoV-2 Infection Protects Against Rechallenge in Rhesus Macaques
21 May, 2020 | 09:27h | UTCSARS-CoV-2 infection protects against rechallenge in rhesus macaques – Science
Related Study: DNA vaccine protection against SARS-CoV-2 in rhesus macaques – Science
Commentaries: Infection With SARS-CoV-2 Protects Against Re-infection – At Least in Rhesus Macaques – Technology Networks AND Prototype Vaccine Protects Monkeys From Coronavirus – The New York Times
Audio Interview: Capitalizing on Immune Responses to Covid-19
21 May, 2020 | 09:26h | UTCAudio Interview: Capitalizing on Immune Responses to Covid-19 – New England Journal of Medicine
Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
21 May, 2020 | 09:23h | UTCRelated: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
Olfactory Dysfunction in COVID-19: Diagnosis and Management
21 May, 2020 | 09:24h | UTCOlfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA
Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford
A Critical Look at A Preprint Inferring the Covid-19 Infection Fatality Rate
21 May, 2020 | 09:21h | UTCA Critical Look at A Preprint Inferring the Covid-19 Infection Fatality Rate – by Hilda Bastian
Original Preprint: The infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv
Video: Personal Protective Equipment and Covid-19
20 May, 2020 | 09:55h | UTCPersonal Protective Equipment and Covid-19 – New England Journal of Medicine
Why do Some COVID-19 Patients Infect Many Others, Whereas Most Don’t Spread the Virus at All?
20 May, 2020 | 09:52h | UTC
Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City
20 May, 2020 | 09:56h | UTCCommentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI
Serology for SARS-CoV-2: Apprehensions, Opportunities, and the Path Forward
20 May, 2020 | 09:53h | UTCSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forward – Science Immunology
Lack of Cross-neutralization by SARS Patient Sera Towards SARS-CoV-2
20 May, 2020 | 09:49h | UTC
[Preprint] The Infection Fatality Rate of COVID-19 Inferred from Seroprevalence Data
20 May, 2020 | 09:51h | UTCThe infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv
Related Commentary on Twitter
The infection fatality rate of COVID-19 inferred from seroprevalence data – a paper by John Ioannidis with a discussion of methodological issues that should stimulate much useful discussion| medRxiv https://t.co/Y2u3LsQW0T
— Jeffrey Flier (@jflier) May 19, 2020
Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19
20 May, 2020 | 09:50h | UTCRelated Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv
Meta-Analysis: Accuracy of Chest CT for detecting COVID-19
20 May, 2020 | 09:49h | UTC